⬇️ Expand this description for helpful links and video chapters.
The results of your immunofluorescence (IF) experiment are impacted by several factors, including which type of microscope and imaging system you choose. In this edition of Learning Lab LIVE!, IF Expert Virginia Bain, PhD, discusses what you should keep in mind when starting an IF experiment.
ℹ️ Download the comprehensive Guide to Successful Immunofluorescence:cst-science.com/usq7ug
💻 Watch the previous Q&A session on fluorophore considerations: • Learning Lab LIVE! Q&A...
🔬 Get in touch with a CST Scientist: www.cellsignal.com/support
Table of Contents:
0:00 Introduction
0:40 Overview
02:36 Magnification considerations
3:46 Widefield epifluorescence basics
4:47 Image capture in widefield
5:40 Widefield imaging settings
7:40 Confocal microscopy basics
9:22 Confocal imaging settings
12:33 Section thickness and
13:34 When to consider using z-stacks
14:22 Using validated reagents or validation yourself
16:33 Sample quality
17:46 What are the limitations of epifluorescenct vs. confocal microscopy?
18:58 How can I deal with high background in parrafin-embedded tissues when performing immunofluorescence?
20:43 Any tips for immunofluorescence combined with in situ hybridization?
22:25 How do different blocking buffers compare of IF?
24:24 What instrument is best for imaging protein localization?
25:54 Can I image whole brain with confocal?
27:19 What fixation is best for brain tissue? Is it better to use frozen?
28:23 What's the difference between and inverted and upright microscopes?
About CST®: Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools to the biomedical research community. Our employees operate worldwide from our U.S. headquarters in Massachusetts, and our offices in the Netherlands, China, and Japan. cellsignal.com/about
All trademarks are the property of their respective owners. For the most up-to-date trademark information, please visit www.cellsignal.com/trademarks
17 июл 2024
